Significant Prostate Cancer clinical trials

Explore recruiting significant prostate cancer clinical trials.

Recruiting significant prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Significant Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SERENDIPITY: phase III multicentric randomized study assessing the reduction of chronic prostate inflammation with Permixon®

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

ECETEP : Pilot study evaluating PSMA positron emission tomography for monitoring clinically significant prostate cancer after focal HIFU treatment

France

Therapeutic use (Phase IV) EU CTIS Study details

Fully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinically significant prostate cancer

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

EvaluatioN of High-Intensity Focused Ultrasound (HIFU) Hemi-ablation and short-term AndrogeN deprivation therapy Combination to Enhance prostate control for intermediate risk localized prostate cancer: the ENHANCE prospective feasibility trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective Study of Added Value of Florastamin (18F) PET/CT in Localisation of Clinically Significant Prostate Cancer in Patients with PI- Report of Multi-Parametric MRI, Elevated Serum PSA Levels and/or PSA Density and with Clinical Suspicion of Prostate Cancer

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Significant Prostate Cancer trials by city

Significant Prostate Cancer in Toronto Significant Prostate Cancer in Vancouver Significant Prostate Cancer in Montreal Significant Prostate Cancer in Calgary Significant Prostate Cancer in Edmonton Significant Prostate Cancer in Ottawa Significant Prostate Cancer in Winnipeg Significant Prostate Cancer in Quebec City Significant Prostate Cancer in Hamilton Significant Prostate Cancer in Kitchener Significant Prostate Cancer in London Significant Prostate Cancer in Halifax Significant Prostate Cancer in New York Significant Prostate Cancer in Los Angeles Significant Prostate Cancer in Chicago Significant Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease